Back to search

Article

Integrated analysis of cell-free DNA for the early detection of cancer in people with Li-Fraumeni Syndrome

2022-10-11

Abstract excerpt

<h4>Summary</h4> Despite advances in cancer therapeutics, early detection is often the best prognostic indicator for survival ( 1 ). People with Li-Fraumeni syndrome harbor a germline pathogenic variant in the tumor suppressor gene TP53 ( 2 ) and face a near 100% lifetime risk of developing a wide spectrum of, often multiple, cancers ( 3 ). TP53 mutation carriers routinely undergo intensive surveillance protocols...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
a69a5461-c1c5-5c2e-aea9-9abd1b13da19
DOI
10.1101/2022.10.07.22280848
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Integrated analysis of cell-free DNA for the early detection of cancer in people with Li-Fraumeni SyndromeDOI 10.1101/2022.10.07.22280848
Select a neighboring publication to make it the new centre.